期刊文献+

湖北地区健康人群缺血修饰白蛋白血清水平参考区间的建立及临床应用 被引量:2

The Establishment and Application of the Reference Interval of Ischemia Modified Albumin in Healthy Population of Hubei Area
下载PDF
导出
摘要 目的:应用美国临床实验室标准化委员会颁布的CLSIC28-A3文件建立湖北地区健康人群缺血修饰白蛋白(IMA)的参考区间,并采用急性冠状动脉综合征(ACS)心肌缺血患者和健康人群验证此参考区间的可靠性。方法:按要求选择健康人群血清标本,采用白蛋白钴结合试验测定血清IMA,经统计分析后确定IMA参考区间。选择ACS心肌缺血患者和一批健康人群,同法测定其血清IMA,并与肌钙蛋白I(cTnI)平行检测比较,验证新建立参考区间的可靠性。结果:IMA的参考值为>65.20U/ml。ACS心肌缺血患者的IMA水平为46.00U/ml(95%CI:45.10~47.10),阳性率为98.90%;cTnI的血清水平为3.31ng/ml(95%CI:2.53~4.51),阳性率为93.40%。健康人群的IMA水平为70.20U/ml(95%CI:67.20~73.10);cTnI的血清水平为0.23ng/ml(95%CI:0.21~0.54)。结论:利用CLSIC28-A3文件建立IMA参考区间简便可行,能较客观反映临床症状,有助于缺血性心肌损伤的诊断。 Objective:To establish ischemia modified albumin(IMA)'s reference interval in healthy people of Hubei area and verify the new reference interval in ACS patients and healthy people with the guide of CLSI C28-A3 file.Method:Follow the guide of CLSI C28-A3 file and select reference individual,obtain the blood sample and measure the serum IMA level with the principle of albumin cobalt binding test.The reference interval of IMA was calculated by statistical method.ACS patients and healthy people were selected to verify the new reference interval by measuring IMA and cTnI.Results:The reference interval of IMA in healthy population is above 65.20U/ml.Among ACS patients,the serum level of IMA and cTnI were 46.00U/ml(95%CI:45.10~47.10),3.31ng/ml(95%CI:2.53~4.51),respectively.IMA and cTnI levels were 70.20U/ml(95%CI:67.20~73.10),0.23ng/ml(95%CI:0.21~0.54)in healthy people,respectively.Conclusion:The file of CLSI C28-A3 played a good guiding role in the establishment of reference interval,and the new reference interval of IMA in Hubei area was in accordance with clinical symptoms.
出处 《微循环学杂志》 2011年第4期49-50,55,I0003,共4页 Chinese Journal of Microcirculation
关键词 缺血修饰白蛋白 参考区间 急性冠状动脉综合征 Ischemia modified albumin Reference intervals Acute coronary syndrome
  • 相关文献

参考文献9

  • 1Baror D, Curtis G, Rao N, et al. Characterization of the Co^2+ and Ni^2+ binding amino-acid residuces of the N-terminus of hu-man albumin. Eur J Biochem, 2001, 268(1) : 42-47.
  • 2中国合格评定国家认可委员会.医学实验室质量和能力认可准则(ISO15189:2007).CNAS-CL02,2008:1-37.
  • 3CLSI. Defining,establishing and verifying reference intervals in the clinical laboratory; approved guideline-third edition, C28-A3. CLSI, 2008:28-30.
  • 4Antman EM, Anbe IT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation my- ocardial infarction;A report of the American College of Cardiolo- gy/American Heart Association Task Foree on Practice Guide- lines (Committee to Revise the 1999 Guidelines for the Manage- ment of patients with acute myoeardial infarction). J Am Coil Cardiol, 2004, 44(3): ElsE211.
  • 5Pollack CV Jr, Roe MT, Peterson ED. 2002 update to the ACC/ AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial in-farction:im-plications for emergency department practice. Ann Emerg Med, 2003, 41(3): 355-369.
  • 6陈桂山,杨有业,温冬梅,缪丽韶,梁锦胜.临床生化检验项目生物参考区间适用性验证探讨[J].中华检验医学杂志,2008,31(2):170-174. 被引量:40
  • 7Van Belle E, DallongeviUe J, Vicaut E, et M. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J, 2010, 159(4) :570-576.
  • 8Karahan SC, Sonmez M, Saglam F,et al. Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polyeythemia vera? Hematology, 2010,15(3):151-156.
  • 9沈晓丽,邢超,韩莉莉,林粼,林立芳,邓玉莲,浦晓东,胡锡衷.缺血修饰白蛋白对急性心肌缺血早期诊断价值的探讨[J].中华心血管病杂志,2007,35(9):814-817. 被引量:25

二级参考文献21

  • 1Fuentes-Arderiu X, Mas-Serra R, Aluma-Trullas A, et al. Guideline for the production of multicentre physiological reference values using the same measurement system. A proposal of the Catalan Association for Clinical Laboratory Sciences. Clin Chem Lab Med ,2004,42:778-782.
  • 2NCCLS C28-A2 How to Define and Reference Intervals in the Clinical Laboratory. NCCLS,2000.
  • 3NCCLS EP9-A Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline-Second Edition. NCCLS, 1995.
  • 4NCCLS EP5 -A2 Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition. NCCLS, 1999.
  • 5中华人民共和国卫生部.医疗机构临床实验室管理办法及配套文件.2006:59-62.
  • 6Solberg HE, Stature D. International Federation of Clinical Chemistry IFCC. IFCC recommendation-theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reverence values. Clin Chim Acta, 1991,202:S5-11.
  • 7Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med,2000,19(4) :311-315.
  • 8Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem,2003, 49(4) :581-585.
  • 9Roy D, Quiles J, Gaze DC,et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 2006,92(1) : 113-114.
  • 10Peacock F, Morris DL, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J,2006,152(2) :253-262.

共引文献63

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部